Target intelligence / Profile preview

Carcinoembryonic antigen-related cell adhesion molecule pseudogene 7 (CEACAMP7)

Target: CEACAMP7
Molecular classification: Pseudogene, Immunoglobulin superfamily (as gene family context), Other

Overview

Carcinoembryonic antigen-related cell adhesion molecule pseudogene 7 (CEACAMP7) is categorized as a pseudogene within the CEA gene family cluster on human chromosome 19[2][6]. Unlike protein-coding CEACAM members (such as CEACAM1, CEACAM5, CEACAM6, etc.) that participate in cell adhesion, immune modulation, and serve as cancer biomarkers[1][3][7], CEACAMP7 is not known to encode a functional protein and has no established biological, pathophysiological, or clinical significance. It is considered a genetic sequence related to the CEA family, but its function is essentially null, and it is not regarded as a therapeutic target[2][6][8].

Other names: CEACAM28PCGM14carcinoembryonic antigen gene family member 14carcinoembryonic antigen related cell adhesion molecule pseudogene 7carcinoembryonic antigen-related cell adhesion molecule 28, pseudogene

Biological functions

None (pseudogenes do not encode functional proteins or have known biological functions)

Disease associations

None (no documented disease associations specific to CEACAMP7)

Beyond the preview

Go deeper on Carcinoembryonic antigen-related cell adhesion molecule pseudogene 7 (CEACAMP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carcinoembryonic antigen-related cell adhesion molecule pseudogene 7 (CEACAMP7).

Explore the full profile